Retractable Technologies (RVP) Cash from Financing Activities (2010 - 2026)
Retractable Technologies (RVP) reported Cash from Financing Activities of -$146823.0 for Q1 2026, down 5.23% on a YoY basis from -$154924.1 in Q1 2025, and down 1.49% quarter-over-quarter from -$144673.0 in Q4 2025.
Retractable Technologies (RVP) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Retractable Technologies has reported Cash from Financing Activities for 17 years, with the latest figure at -$146823.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Financing Activities fell 5.23% year-over-year to -$146823.0; the trailing twelve-month figure through Mar 2026 stood at -$574617.0 (down 5.69% YoY), and the FY2025 full-year result was -$567321.0, down 5.96% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at -$146823.0, down from -$144673.0 in the prior quarter.
- The five-year high for Cash from Financing Activities was $4.7 million in Q3 2022, with the low at -$2.8 million in Q4 2022.
- Historically, Cash from Financing Activities has averaged $275598.9 across 5 years, with a median of -$134252.0 in 2024.
- The largest YoY upside for Cash from Financing Activities was 95.1% in 2023 against a maximum downside of 4922.48% in 2023.
- Retractable Technologies' Cash from Financing Activities stood at -$2.8 million in 2022, then jumped by 95.1% to -$136357.0 in 2023, then slipped by 0.47% to -$136996.0 in 2024, then retreated by 5.6% to -$144673.0 in 2025, then declined by 1.49% to -$146823.0 in 2026.
- The last three Cash from Financing Activities figures came in at -$146823.0 (Q1 2026), -$144673.0 (Q4 2025), and -$142396.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -1.35 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -414.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -13.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | -255.24 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -308.70 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -50.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -75.80 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | -48.13 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -11.00 Mn |
| 10 | Retractable Technologies | 19.78 Mn | -15.84 Mn | -838,408.00 | -146,823.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -146,823.00 |
| Mar 31, 2026 | -146,823.00 |
| Dec 31, 2025 | -144,673.00 |
| Dec 31, 2025 | -144,673.00 |
| Sep 30, 2025 | -142,396.00 |
| Sep 30, 2025 | -142,396.00 |
| Jun 30, 2025 | -140,725.00 |
| Jun 30, 2025 | -140,725.00 |
| Mar 31, 2025 | -139,527.00 |
| Mar 31, 2025 | -139,527.00 |
| Dec 31, 2024 | -136,996.00 |
| Dec 31, 2024 | -136,996.00 |
| Sep 30, 2024 | -134,252.00 |
| Sep 30, 2024 | -134,252.00 |
| Jun 30, 2024 | -132,926.00 |
| Jun 30, 2024 | -132,926.00 |
| Mar 31, 2024 | -131,259.00 |
| Mar 31, 2024 | -131,259.00 |
| Dec 31, 2023 | -136,357.00 |
| Dec 31, 2023 | -136,357.00 |